Literature DB >> 12493608

The effect of the 'classic' ketogenic diet on animal seizure models.

Paaladinesh Thavendiranathan1, Catherine Chow, Stephen Cunnane, W McIntyre Burnham.   

Abstract

Bough et al. have recently demonstrated anticonvulsant effects of the 'classic' ketogenic diet (KD) in the pentylenetetrazol infusion model in rats. Proconvulsant effects were seen, however, when the 'classic' diet was tested against maximal electroshock (MES) seizures. These differing results may reflect the fact that the two models involve different kinds of epileptogenic stimulus, or, as Bough et al. note that the two tests involve different stimulation paradigms. The pentylenetetrazol infusion paradigm is a threshold test, whereas the MES test employs a stimulus which is well above threshold. The present experiments were designed to test the effects of the 'classic' KD against seizures triggered in rats by both threshold and suprathreshold levels of electricity and pentylenetetrazol. The threshold tests employed were the pentylenetetrazol infusion test, and the threshold electroconvulsive shock (ECS) test. The subcutaneous pentylenetetrazol (scMET) test was also included, since it is sometimes considered to be a 'threshold' test. The suprathreshold tests employed were the maximal pentylenetetrazol test (MMT) and the maximal electroshock test (MES). The KD failed to suppress seizures in either of the tests involving suprathreshold stimulation (MMT and MES), although there was a significant increase in latency in the MMT test. Small but significant threshold elevations (15-20%) were seen, however, in both the pentylenetetrazol infusion test and the ECS threshold test. No seizure suppression was seen in the scMET test, which actually employs a suprasthreshold stimulus. These data indicate that the KD has significant anticonvulsant effects against both chemically and electrically triggered seizures, but that they consist of small elevations in threshold which will be seen only when threshold measures are used.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12493608     DOI: 10.1016/s0006-8993(02)03744-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

2.  Protective effect of the ketogenic diet in Scn1a mutant mice.

Authors:  Stacey B B Dutton; Nikki T Sawyer; Franck Kalume; Patricia Jumbo-Lucioni; Karin Borges; William A Catterall; Andrew Escayg
Journal:  Epilepsia       Date:  2011-07-29       Impact factor: 5.864

Review 3.  Hypothalamic hormones and metabolism.

Authors:  Liu Lin Thio
Journal:  Epilepsy Res       Date:  2012-07       Impact factor: 3.045

4.  Efficacy of the ketogenic diet in the 6-Hz seizure test.

Authors:  Adam L Hartman; Megan Lyle; Michael A Rogawski; Maciej Gasior
Journal:  Epilepsia       Date:  2007-12-06       Impact factor: 5.864

5.  Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies.

Authors:  Marwan Maalouf; Jong M Rho
Journal:  J Neurosci Res       Date:  2008-11-15       Impact factor: 4.164

Review 6.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

7.  A ketogenic diet protects DBA/1 and Scn1aR1407X/+ mice against seizure-induced respiratory arrest independent of ketosis.

Authors:  Megan S Crotts; YuJaung Kim; Eduardo Bravo; George B Richerson; Frida A Teran
Journal:  Epilepsy Behav       Date:  2021-09-29       Impact factor: 2.937

8.  Proconvulsant effects of the ketogenic diet in electroshock-induced seizures in mice.

Authors:  Iwona Zarnowska; Jarogniew J Luszczki; Tomasz Zarnowski; Piotr Wlaz; Stanislaw J Czuczwar; Maciej Gasior
Journal:  Metab Brain Dis       Date:  2016-09-20       Impact factor: 3.584

9.  A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy.

Authors:  Tsz Hong Law; Emma S S Davies; Yuanlong Pan; Brian Zanghi; Elizabeth Want; Holger A Volk
Journal:  Br J Nutr       Date:  2015-09-04       Impact factor: 3.718

Review 10.  Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.

Authors:  Carmela Giordano; Maddalena Marchiò; Elena Timofeeva; Giuseppe Biagini
Journal:  Front Neurol       Date:  2014-04-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.